Serotonin and noradrenaline reuptake inhibition strengthens the bladder closing muscle
Vollmer, H.
Medizinische Monatsschrift für Pharmazeuten 28(12): 455-456
2005
ISSN/ISBN: 0342-9601 PMID: 16389881 Document Number: 592578
Document emailed within 1 workday
Related Documents
Posternak, M.A.; Zimmerman, M. 2005: Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study Journal of Clinical Psychiatry 66(6): 705-707Bishop, J.R.; Ellingrod, V.L.; Akroush, M.; Moline, J. 2009: The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives Human Psychopharmacology 24(3): 207-215
DeVane, C.L. 1992: Pharmacokinetics of the selective serotonin reuptake inhibitors Journal of Clinical Psychiatry 53 Suppl: 13-20
Fichtner, C.G.; Jobe, T.H.; Braun, B.G. 1994: Possible therapeutic window for serotonin reuptake inhibitors Journal of Clinical Psychiatry 55(1): 36-38
Leonard, B.E. 1988: Pharmacological effects of serotonin reuptake inhibitors Journal of Clinical Psychiatry 49 Suppl: 12-17
Mahendran, R. 2006: The risk of suicidality with selective serotonin reuptake inhibitors Annals of the Academy of Medicine Singapore 35(2): 96-99
Ireland, R.R. 2002: Pharmacologic considerations for serotonin reuptake inhibitor use by aviators Aviation Space and Environmental Medicine 73(5): 421-429
Mayer, L.E.; Walsh, B.T. 1998: The use of selective serotonin reuptake inhibitors in eating disorders Journal of Clinical Psychiatry 59(Suppl): 28-34
Dudek, D.; Zieba, A.; Siwek, M.; Wróbel, A. 2004: Selective serotonin reuptake inhibitors--current knowledge Psychiatria Polska 38(3): 507-524
Sherman, T.L.; McDougle, C.J.; Price, L.H. 1993: Paroxetine: a new serotonin reuptake inhibitor for the treatment of depression Connecticut Medicine 57(9): 587-592
Eriksson, E. 1999: Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria International Clinical Psychopharmacology 14(Suppl 2): S27-S33
Condat, A.; Mouren-Simeoni, M.C. 2000: Selective serotonin reuptake inhibitors and depression in the child and adolescent L'Encephale 26(3): 53-60
Pacher, P.ál.; Kecskeméti, V.ér. 2004: Cardiovascular effects of selective serotonin reuptake inhibitor antidepressants Orvosi Hetilap 145(8): 425-431
Sheehan, D.V.; Zak, J.P.; Miller, J.A.; Fanous, B.S. 1988: Panic disorder: the potential role of serotonin reuptake inhibitors Journal of Clinical Psychiatry 49 Suppl: 30-36
Nakielny, J.; Eckett, S. 1994: Selective serotonin reuptake inhibitors. Calculation of costs is incorrect Bmj 309(6961): 1082-3; Author Reply 1085
Dubovsky, S.L. 1994: Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents Journal of Clinical Psychiatry 55(Suppl): 34-44
Cohen, S.M.; Zenser, T.V.; Murasaki, G.; Fukushima, S.; Mattammal, M.B.; Rapp, N.S.; Davis, B.B. 1981: Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase Cancer Research 41(9 Part 1): 3355-3359
Ostroff, R.B.; Nelson, J.C. 1999: Risperidone augmentation of selective serotonin reuptake inhibitors in major depression Journal of Clinical Psychiatry 60(4): 256-259
Tracey, D. 1994: Selective serotonin reuptake inhibitors. Commercial interests should not influence prescribing Bmj 309(6961): 1083-4; Author Reply 1085
Nelson, S.A.; Wilson, G.A.; Tucci, M.; Benghuzzi, H. 2015: The Effect of Selective Serotonin Reuptake Inhibitors and Antidiabetic Drugs on Cardiomyocytes Biomedical Sciences Instrumentation 51: 400-406